**Novo Nordisk Increases Production of Wegovy: What You Need to Know** Novo Nordisk, the pharmaceutical company, has announced that it is ramping up the production of Wegovy, a weight loss drug that has been difficult to find in stores. The company has been facing supply issues and a high demand for the drug, according to CEO Lars Jorgensen. The shortages became more pronounced last year as the drug's popularity surged. Wegovy works by mimicking a hormone that helps reduce food intake and appetite. Clinical trials have shown that Wegovy can reduce body weight by about 15%. However, it comes with a hefty price tag of around $1,300 per month, and many insurance companies do not cover it. The shortages have caused some people to regain the weight they lost while taking the drug. Additionally, some have turned to using prescription Ozempic for weight loss, but it has also faced shortages. Ozempic is essentially the same medication as Wegovy but in a lower dose and is primarily used to regulate blood sugar levels in people with Type 2 diabetes. Novo Nordisk manufactures both drugs.